{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T17:51:28Z","timestamp":1774461088701,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.neulet.2010.05.012","type":"journal-article","created":{"date-parts":[[2010,5,13]],"date-time":"2010-05-13T20:52:07Z","timestamp":1273783927000},"page":"179-183","source":"Crossref","is-referenced-by-count":25,"title":["Cerebrospinal fluid secretory Ca2+-dependent phospholipase A2 activity: A biomarker of blood\u2013cerebrospinal fluid barrier permeability"],"prefix":"10.1016","volume":"478","author":[{"given":"Sonia","family":"Chalbot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tormod","family":"Fladby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inge","family":"Grundke-Iqbal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalid","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2010.05.012_bib1","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1023\/A:1007074420772","article-title":"Inflammatory mediators and modulation of blood\u2013brain barrier permeability","volume":"20","author":"Abbott","year":"2000","journal-title":"Cell Mol. Neurobiol."},{"key":"10.1016\/j.neulet.2010.05.012_bib2","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","article-title":"Statistical methods for assessing agreement between two methods of clinical measurement","volume":"1","author":"Bland","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.neulet.2010.05.012_bib3","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000116919","article-title":"Protein analysis in cerebrospinal fluid. II. Reference values derived from healthy individuals 18\u201388 years of age","volume":"33","author":"Blennow","year":"1993","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.neulet.2010.05.012_bib4","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1373\/clinchem.2009.130286","article-title":"Cerebrospinal fluid secretory Ca2+-dependent phospholipase A2 activity is increased in Alzheimer disease","volume":"55","author":"Chalbot","year":"2009","journal-title":"Clin. Chem."},{"key":"10.1016\/j.neulet.2010.05.012_bib5","doi-asserted-by":"crossref","first-page":"345","DOI":"10.5483\/BMBRep.2008.41.5.345","article-title":"Blood\u2013neural barrier: its diversity and coordinated cell-to-cell communication","volume":"41","author":"Choi","year":"2008","journal-title":"BMB Rep."},{"key":"10.1016\/j.neulet.2010.05.012_bib6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0165-5728(97)00177-X","article-title":"Soluble Fas (Apo-1) levels in cerebrospinal fluid of multiple sclerosis patients","volume":"82","author":"Ciusani","year":"1998","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.neulet.2010.05.012_bib7","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1742-2094-3-26","article-title":"Secreted phospholipase A2 activity in experimental autoimmune encephalomyelitis and multiple sclerosis","volume":"3","author":"Cunningham","year":"2006","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neulet.2010.05.012_bib8","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1177\/1073858405285923","article-title":"Phospholipase A2-generated lipid mediators in the brain: the good, the bad, and the ugly","volume":"12","author":"Farooqui","year":"2006","journal-title":"Neuroscientist"},{"key":"10.1016\/j.neulet.2010.05.012_bib9","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/clinchem\/20.5.571","article-title":"Measurement of IgG and albumin content of cerebrospinal fluid, and its interpretation","volume":"20","author":"Ganrot","year":"1974","journal-title":"Clin. Chem."},{"key":"10.1016\/j.neulet.2010.05.012_bib10","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1148\/radiology.161.3.3786722","article-title":"Multiple sclerosis: gadolinium enhancement in MR imaging","volume":"161","author":"Grossman","year":"1986","journal-title":"Radiology"},{"key":"10.1016\/j.neulet.2010.05.012_bib11","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1007\/s004150070130","article-title":"Incidence of CSF abnormalities in siblings of multiple sclerosis patients and unrelated controls","volume":"247","author":"Haghighi","year":"2000","journal-title":"J. Neurol."},{"key":"10.1016\/j.neulet.2010.05.012_bib12","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/00002093-199706000-00004","article-title":"Blood\u2013cerebrospinal fluid barrier dysfunction for high molecular weight proteins in Alzheimer disease and major depression: indication for disease subsets","volume":"11","author":"Hampel","year":"1997","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.neulet.2010.05.012_bib13","first-page":"75","article-title":"Molecular markers of brain damage: current state and future perspectives","volume":"21","author":"Herrmann","year":"2003","journal-title":"Restor. Neurol. Neurosci."},{"key":"10.1016\/j.neulet.2010.05.012_bib14","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1007\/BF00992509","article-title":"Alterations in the activity of phospholipases A2 in postmortem white matter from patients with multiple sclerosis","volume":"20","author":"Huterer","year":"1995","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neulet.2010.05.012_bib15","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s11095-005-6039-0","article-title":"Enhanced prospects for drug delivery and brain targeting by the choroid plexus\u2013CSF route","volume":"22","author":"Johanson","year":"2005","journal-title":"Pharm. Res."},{"key":"10.1016\/j.neulet.2010.05.012_bib16","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1093\/brain\/awp002","article-title":"Differing roles for members of the phospholipase A2 superfamily in experimental autoimmune encephalomyelitis","volume":"132","author":"Kalyvas","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.neulet.2010.05.012_bib17","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0896-6273(04)00003-0","article-title":"Cytosolic phospholipase A2 plays a key role in the pathogenesis of multiple sclerosis-like disease","volume":"41","author":"Kalyvas","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.neulet.2010.05.012_bib18","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0165-5728(03)00085-7","article-title":"CSF and serum levels of soluble fractalkine (CX3CL1) in inflammatory diseases of the nervous system","volume":"137","author":"Kastenbauer","year":"2003","journal-title":"J. Neuroimmunol."},{"issue":"Pt 5","key":"10.1016\/j.neulet.2010.05.012_bib19","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/brain\/113.5.1477","article-title":"Breakdown of the blood\u2013brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications","volume":"113","author":"Kermode","year":"1990","journal-title":"Brain"},{"key":"10.1016\/j.neulet.2010.05.012_bib20","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1212\/WNL.40.2.229","article-title":"Heterogeneity of blood\u2013brain barrier changes in multiple sclerosis: an MRI study with gadolinium-DTPA enhancement","volume":"40","author":"Kermode","year":"1990","journal-title":"Neurology"},{"key":"10.1016\/j.neulet.2010.05.012_bib21","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1084\/jem.20050665","article-title":"Cytosolic phospholipase A2 alpha-deficient mice are resistant to experimental autoimmune encephalomyelitis","volume":"202","author":"Marusic","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.neulet.2010.05.012_bib22","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.2174\/1381612053507521","article-title":"Phospholipase A2 inhibitors as potential anti-inflammatory agents","volume":"11","author":"Meyer","year":"2005","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.neulet.2010.05.012_bib23","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1742-2094-3-28","article-title":"Secretory PLA2-IIA: a new inflammatory factor for Alzheimer's disease","volume":"3","author":"Moses","year":"2006","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neulet.2010.05.012_bib24","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/glia.10296","article-title":"Extracellular phospholipase A2 inhibitors suppress central nervous system inflammation","volume":"44","author":"Pinto","year":"2003","journal-title":"Glia"},{"key":"10.1016\/j.neulet.2010.05.012_bib25","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1212\/01.WNL.0000144352.67102.BC","article-title":"CSF characteristics in early-onset multiple sclerosis","volume":"63","author":"Pohl","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.neulet.2010.05.012_bib26","first-page":"449","article-title":"beta-Amyloid and interleukin-1beta induce persistent NF-kappaB activation in rat primary glial cells","volume":"16","author":"Samuelsson","year":"2005","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.neulet.2010.05.012_bib27","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.23.021704.115707","article-title":"Immunology of multiple sclerosis","volume":"23","author":"Sospedra","year":"2005","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.neulet.2010.05.012_bib28","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1515\/CCLM.2008.194","article-title":"A new general regression-based approach for method comparison studies","volume":"46","author":"Sotgia","year":"2008","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.neulet.2010.05.012_bib29","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1194\/jlr.R300016-JLR200","article-title":"Phospholipase A2 in the central nervous system: implications for neurodegenerative diseases","volume":"45","author":"Sun","year":"2004","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.neulet.2010.05.012_bib30","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/jmri.21478","article-title":"Is NSF only the tip of the \u201cgadolinium toxicity\u201d iceberg?","volume":"28","author":"Thomsen","year":"2008","journal-title":"J. Magn. Reson. Imaging"},{"key":"10.1016\/j.neulet.2010.05.012_bib31","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3109\/00365517709091496","article-title":"Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values","volume":"37","author":"Tibbling","year":"1977","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.neulet.2010.05.012_bib32","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.jaci.2005.08.011","article-title":"Secretory phospholipases A2 in inflammatory and allergic diseases: not just enzymes","volume":"116","author":"Triggiani","year":"2005","journal-title":"J. Allergy Clin. Immunol."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394010005756?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394010005756?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T16:44:08Z","timestamp":1591289048000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394010005756"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S0304394010005756"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2010.05.012","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}